Industry Looks At IRA Drawbacks And Silver Linings
Drug Pricing Changes Were Top Of Mind At J.P. Morgan
Industry leaders are concerned about the outlook for small molecule drugs in particular, but execs at the J.P. Morgan Healthcare Conference were also optimistic there could be chances to shape the implementation of certain policies.
